|
GNPTAB expression based on
|
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.64980000000004E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.61329999999582E-05 |
| Normal-vs-Stage2 |
6.474400E-02 |
| Normal-vs-Stage3 |
9.096100E-03 |
| Normal-vs-Stage4 |
5.886000E-02 |
| Stage1-vs-Stage2 |
3.979600E-01 |
| Stage1-vs-Stage3 |
4.645200E-01 |
| Stage1-vs-Stage4 |
3.631400E-01 |
| Stage2-vs-Stage3 |
7.881000E-01 |
| Stage2-vs-Stage4 |
9.736600E-01 |
| Stage3-vs-Stage4 |
7.544600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.13310000000333E-05 |
| Normal-vs-AfricanAmerican |
5.496000E-02 |
| Normal-vs-Asian |
8.021700E-02 |
| Caucasian-vs-AfricanAmerican |
8.073200E-01 |
| Caucasian-vs-Asian |
1.565570E-01 |
| AfricanAmerican-vs-Asian |
3.610400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.925600E-02 |
| Normal-vs-Female |
2.17120000000071E-05 |
| Male-vs-Female |
3.832400E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.973960E-04 |
| Normal-vs-Age(41-60Yrs) |
1.739550E-03 |
| Normal-vs-Age(61-80Yrs) |
3.297100E-03 |
| Normal-vs-Age(81-100Yrs) |
9.195800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.267800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.381800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.796190E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.487400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.640200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.350200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.528600E-01 |
| Classical-VS-Follicular |
7.801400E-03 |
| Classical-VS-Other |
9.615500E-02 |
| Classical-VS-Normal |
2.23030000001678E-06 |
| Tall-VS-Follicular |
1.461180E-01 |
| Tall-VS-Other |
1.239840E-01 |
| Tall-VS-Normal |
1.516460E-02 |
| Follicular-VS-Other |
4.791800E-01 |
| Follicular-VS-Normal |
2.267800E-01 |
| Other-VS-Normal |
6.759200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.696740E-03 |
| Normal-vs-N1 |
5.067600E-01 |
| N0-vs-N1 |
1.215170E-01 |
|
|
